MedPath

Spatial Cognition Assessment in Virtual Reality

Not Applicable
Recruiting
Conditions
Spatial Neglect
Registration Number
NCT05723146
Lead Sponsor
Université Paris Cité
Brief Summary

Unilateral spatial neglect (USN) is a highly-prevalent neuropsychological syndrome following a cerebral stroke characterized by massive impairments in daily life. The evaluation and the rehabilitation of USN encounter many limits whereas immersive virtual reality (VR) could be an efficient tool to go through these limits by imitating an environment of perception and action very close to the real one. The investigators will test a multisensory battery of evaluation based on VR for the diagnostic of USN.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • unilateral right stroke
Exclusion Criteria
  • epilepsy / migraine
  • craniotomy
  • major sensory/motor deficit
  • severe cognitive impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Omissions in cancellation tasksBaseline

Number and localization in space

Number of the cubes in each side of space in the Baking Tray TasksBaseline

16 cubes have to be disposed

Detections in the localization tasksBaseline

Number and localization in space

Deviation in line bisection tasksBaseline

Deviation of the bisection from the true center of the lines (in mm)

Secondary Outcome Measures
NameTimeMethod
Duration of eye fixation in each side of space during VR tasksBaseline

Collected thanks to the VR headset

Completion time of each taskBaseline

(in s)

Score in the Catherine Bergego Scale (CBS)Assessed within the same week as Baseline

Functional assessment scored by the occupational therapists. Minimum: 0 / Maximum: 30 / Higher scores mean a better outcome

Trial Locations

Locations (1)

Université Paris Cité

🇫🇷

Paris, France

Université Paris Cité
🇫🇷Paris, France
Alma Guilbert
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.